NKGen Biotech Statistics

Total Valuation

NKGen Biotech has a market cap or net worth of $12.00 million. The enterprise value is $39.29 million.

Market Cap	12.00M
Enterprise Value	39.29M

Important Dates

The next estimated earnings date is Tuesday, November 26, 2024, after market close.

Earnings Date	Nov 26, 2024
Ex-Dividend Date	n/a

Share Statistics

NKGen Biotech has 36.02 million shares outstanding. The number of shares has increased by 250.53% in one year.

Current Share Class	36.02M
Shares Outstanding	36.02M
Shares Change (YoY)	+250.53%
Shares Change (QoQ)	+10.18%
Owned by Insiders (%)	14.22%
Owned by Institutions (%)	12.55%
Float	16.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.02

Current Ratio	0.02
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-13.28

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-106.85%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.40M
Employee Count	63
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NKGen Biotech has paid $7,000 in taxes.

Income Tax	7,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.82% in the last 52 weeks. The beta is 0.52, so NKGen Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	-88.82%
50-Day Moving Average	0.37
200-Day Moving Average	1.07
Relative Strength Index (RSI)	48.95
Average Volume (20 Days)	899,997

Short Selling Information

The latest short interest is 713,973, so 1.98% of the outstanding shares have been sold short.

Short Interest	713,973
Short Previous Month	432,022
Short % of Shares Out	1.98%
Short % of Float	4.30%
Short Ratio (days to cover)	0.29

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-31.42M
Pretax Income	-80.01M
Net Income	-88.25M
EBITDA	-30.23M
EBIT	-31.42M
Earnings Per Share (EPS)	-$4.35

Full Income Statement

Balance Sheet

The company has $79,000 in cash and $28.09 million in debt, giving a net cash position of -$28.01 million or -$0.78 per share.

Cash & Cash Equivalents	79,000
Total Debt	28.09M
Net Cash	-28.01M
Net Cash Per Share	-$0.78
Equity (Book Value)	-69.72M
Book Value Per Share	-2.71
Working Capital	-50.16M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-21.54M
Capital Expenditures	n/a
Free Cash Flow	-21.54M
FCF Per Share	-$0.60

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NKGen Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-250.53%
Shareholder Yield	-250.53%
Earnings Yield	-782.84%
FCF Yield	-191.04%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1